About PathoQuest
PathoQuest is a company based in Paris (France) founded in 2010 was acquired by Charles River Laboratories in January 2026.. PathoQuest has raised $9.99 million across 4 funding rounds from investors including Charles River Laboratories, Eurazeo and Idinvest Partners. PathoQuest offers products and services including iDTECT Platform, Adventitious Virus Testing, Cell Line Characterization, and Raw Material Testing. PathoQuest operates in a competitive market with competitors including Prenetics, Karius, Day Zero Diagnostics, OpGen and Clear Labs, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.99 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Charles River Laboratories
& 9 more
-
Employee Count
Employee Count
-
Acquired by
Charles River Laboratories
(Jan 13, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PathoQuest
PathoQuest offers a comprehensive portfolio of products and services, including iDTECT Platform, Adventitious Virus Testing, Cell Line Characterization, and Raw Material Testing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for viral safety and genetic characterization of biopharmaceuticals
Detects viral contamination in manufacturing processes
Screens and tests manufacturing cells for stability
Screens high-risk inputs for potential contaminants
Unlock access to complete
Unlock access to complete
Funding Insights of PathoQuest
PathoQuest has successfully raised a total of $9.99M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(11 Jul 2013)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series B - PathoQuest | Valuation | SHS | |
| Sep, 2019 | Amount | Series B - PathoQuest | Valuation | Kurma Partners , Charles River Laboratories | |
| Sep, 2019 | Amount | Debt – Venture - PathoQuest | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PathoQuest
PathoQuest has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Charles River Laboratories, Eurazeo and Idinvest Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare-focused private equity investments are managed by SHS Capital.
|
Founded Year | Domain | Location | |
|
Private equity investments are made in companies across diverse sectors.
|
Founded Year | Domain | Location | |
|
Biotech startups are funded through venture capital in life sciences.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PathoQuest
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PathoQuest
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pathoquest Comparisons
Competitors of PathoQuest
PathoQuest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Karius, Day Zero Diagnostics, OpGen and Clear Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| domain | founded_year | HQ Location |
Food safety technologies are provided for pathogen identification.
|
|
| domain | founded_year | HQ Location |
Viral infection treatments are developed using nucleic acid hybrid chemistry.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pathoquest
Frequently Asked Questions about PathoQuest
When was PathoQuest founded?
PathoQuest was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is PathoQuest located?
PathoQuest is headquartered in Paris, France.
Is PathoQuest a funded company?
PathoQuest is a funded company, having raised a total of $9.99M across 4 funding rounds to date. The company's 1st funding round was a Series B of $5.03M, raised on Jul 11, 2013.
What does PathoQuest do?
PathoQuest was founded in 2010 and is based in Paris, France. Operations focus on the biotechnology sector, where next-generation sequencing is integrated with sample preparation, cloud-based bioinformatics, and a pathogen genome database for automated analysis. Services support quality control in biologicals and infection diagnosis through these combined technologies.
Who are the top competitors of PathoQuest?
PathoQuest's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
What products or services does PathoQuest offer?
PathoQuest offers iDTECT Platform, Adventitious Virus Testing, Cell Line Characterization, and Raw Material Testing.
Who are PathoQuest's investors?
PathoQuest has 10 investors. Key investors include Charles River Laboratories, Eurazeo, Idinvest Partners, Kurma Partners, and SHS Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.